Latest Breaking News On - Base care - Page 3 : vimarsana.com

Share this article Share this article HONG KONG, Feb. 8, 2021 /PRNewswire/ Basecare (Suzhou Basecare Medical Corporation Limited), an innovative assisted reproductive genetic testing enterprise, today officially listed on the main board of HKEX (HKG: 2170). Approximately 66.667 million shares were issued and total funds raised was $HK1.82 billion. The initial price was $HK27.36 per share and shares were oversubscribed 403 times, up 60 percent as of the time of this press release, with a total market value of $HK8.92 billion. This listing represents an important milestone in the history of Basecare, a leading-edge company that has attracted seven well-known global cornerstone investors including Orbited, Lake Bleu Capital, China Reform Overseas, Affin Hwang AM, WinTwin Capital, Foresight and Ivy Capital. Basecare has long been optimistic about the internationalization and diversification of the capital market of Hong Kong, and bullish on China s assisted reproduction industry. A

United statesNational health commissionNational medical products administrationNational innovative medical device special approvalInnovative medical device specialBase careஒன்றுபட்டது மாநிலங்களில்தேசிய ஆரோக்கியம் தரகுதேசிய புதுமையானது மருத்துவ சாதனம் சிறப்பு ஒப்புதல்புதுமையானது மருத்துவ சாதனம் சிறப்புஅடித்தளம் பராமரிப்பு